Generic rinvoq?

Rinvoq is the brand name for upadacitinib, a JAK1 inhibitor. As of now, there isn’t a generic version available in the U.S. or many other markets. Generics usually come only after patent protection and exclusivity periods end, which can be many years and depend on patents, extensions, and legal status in each country.

If you’re trying to save money, you might consider:
- Checking if AbbVie offers a patient assistance or savings program for Rinvoq.
- Talking to your pharmacist or insurer about copays or alternative JAK inhibitors that might have generics sooner in your country.
- Exploring other treatment options (different drugs or dosing) if appropriate for your condition, under your prescriber’s guidance.

If you tell me your country, I can try to look up the current generic status there and suggest concrete alternatives or cost-saving options.